These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 3759259)

  • 1. Local intranasal immunotherapy with high-dose polymerized ragweed extract.
    Georgitis JW; Nickelsen JA; Wypych JI; Barde SH; Clayton WF; Reisman RE
    Int Arch Allergy Appl Immunol; 1986; 81(2):170-3. PubMed ID: 3759259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Local nasal immunotherapy: efficacy of low-dose aqueous ragweed extract.
    Georgitis JW; Nickelsen JA; Wypych JI; Kane JH; Reisman RE
    J Allergy Clin Immunol; 1985 Apr; 75(4):496-500. PubMed ID: 3980884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Local nasal immunotherapy for ragweed-allergic rhinitis. III. A second year of treatment.
    Nickelsen JA; Georgitis JW; Mueller UR; Kane J; Wypych JI; Goldstein S; Reisman RE; Arbesman CE
    Clin Allergy; 1983 Nov; 13(6):509-19. PubMed ID: 6640886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Controlled studies of intranasal immunotherapy for ragweed pollenosis.
    Mathews KP; Bayne NK; Banas JM; McLean JA; Bacon J
    Int Arch Allergy Appl Immunol; 1981; 66(2):218-24. PubMed ID: 6169652
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Local intranasal immunotherapy for ragweed allergic rhinitis. II. Immunologic response.
    Nickelsen JA; Goldstein S; Mueller U; Wypych J; Reisman RE; Arbesman CE
    J Allergy Clin Immunol; 1981 Jul; 68(1):41-5. PubMed ID: 6972401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical efficacy and tolerability of a steady dosage schedule of local nasal immunotherapy. Results of preseasonal treatment in grass pollen rhinitis.
    Bertoni M; Cosmi F; Bianchi I; Di Berardino L
    Ann Allergy Asthma Immunol; 1999 Jan; 82(1):47-51. PubMed ID: 9988206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of polymerized and unpolymerized antigen E for immunotherapy of ragweed allergy.
    Metzger WJ; Patterson R; Zeiss R; Irons JS; Pruzansky JJ; Suszko IM; Levitz D
    N Engl J Med; 1976 Nov; 295(21):1160-4. PubMed ID: 824555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sublingual immunotherapy in patients with allergic rhinoconjunctivitis caused by ragweed pollen.
    Skoner D; Gentile D; Bush R; Fasano MB; McLaughlin A; Esch RE
    J Allergy Clin Immunol; 2010 Mar; 125(3):660-6, 666.e1-666.e4. PubMed ID: 20153030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Seasonal changes in IgE antibodies and their relationship to IgG antibodies during immunotherapy for ragweed hay fever.
    Yunginger JW; Gleich GJ
    J Clin Invest; 1973 May; 52(5):1268-75. PubMed ID: 4735589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunologic effects of encapsulated short ragweed extract: a potent new agent for oral immunotherapy.
    Litwin A; Flanagan M; Entis G; Gottschlich G; Esch R; Gartside P; Michael JG
    Ann Allergy Asthma Immunol; 1996 Aug; 77(2):132-8. PubMed ID: 8760779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Local nasal immunotherapy for birch allergic rhinitis with extract in powder form.
    Andri L; Senna G; Andri G; Dama A; Givanni S; Betteli C; Dimitri G; Falagiani P; Mezzelani P
    Clin Exp Allergy; 1995 Nov; 25(11):1092-9. PubMed ID: 8581842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Controlled evaluation of allergoid in the immunotherapy of ragweed hay fever.
    Norman PS; Lichtenstein LM; Kagey-Sobotka A; Marsh DG
    J Allergy Clin Immunol; 1982 Oct; 70(4):248-60. PubMed ID: 6181113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decrease of allergen-specific T-cell response induced by local nasal immunotherapy.
    Giannarini L; Maggi E
    Clin Exp Allergy; 1998 Apr; 28(4):404-12. PubMed ID: 9641566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunotherapy with a ragweed-toll-like receptor 9 agonist vaccine for allergic rhinitis.
    Creticos PS; Schroeder JT; Hamilton RG; Balcer-Whaley SL; Khattignavong AP; Lindblad R; Li H; Coffman R; Seyfert V; Eiden JJ; Broide D;
    N Engl J Med; 2006 Oct; 355(14):1445-55. PubMed ID: 17021320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Further evaluation of local intranasal immunotherapy with aqueous and allergoid grass extracts.
    Georgitis JW; Clayton WF; Wypych JI; Barde SH; Reisman RE
    J Allergy Clin Immunol; 1984 Nov; 74(5):694-700. PubMed ID: 6389648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Local intranasal immunotherapy for ragweed allergic rhinitis. I. Clinical response.
    Nickelsen JA; Goldstein S; Mueller U; Wypych J; Reisman RE; Arbesman CE
    J Allergy Clin Immunol; 1981 Jul; 68(1):33-40. PubMed ID: 7240598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of immunotherapy schedules for injection treatment of ragweed pollen hay fever.
    Van Metre TE; Adkinson NF; Amodio FJ; Kagey-Sobotka A; Lichtenstein LM; Mardiney MR; Norman PS; Rosenberg GL
    J Allergy Clin Immunol; 1982 Feb; 69(2):181-93. PubMed ID: 7056949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preseasonal intranasal immunotherapy with nebulized short ragweed extract.
    Welsh PW; Zimmermann EM; Yunginger JW; Kern EB; Gleich GJ
    J Allergy Clin Immunol; 1981 Mar; 67(3):237-42. PubMed ID: 7007474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunologic effect and tolerability of intra-seasonal subcutaneous immunotherapy with an 8-day up-dosing schedule to 10,000 standardized quality-units: a double-blind, randomized, placebo-controlled trial.
    Pfaar O; Wolf H; Klimek L; Schnitker J; Wüstenberg E
    Clin Ther; 2012 Oct; 34(10):2072-81. PubMed ID: 23063373
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nasal immunotherapy in pollen-sensitive children.
    Cserháti E; Mezei G
    Allergy; 1997; 52(33 Suppl):40-4. PubMed ID: 9188948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.